$111.71 +0.49 (%) Gilead Sciences Inc - NASDAQ

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Achillion

    IBD | May. 20, 2015 | 18:39PM EST
  2. Achillion Dives As J&J Hep C Deal Chills Buyout Buzz

    IBD | May. 20, 2015 | 13:52PM EST
  3. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  4. 5 NASDAQ Healthcare Stocks With The Highest EPS

    Benzinga | May. 20, 2015 | 09:23AM EST
  5. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  6. Achillion, J&J To Jointly Develop Hepatitis C Drugs

    IBD | May. 19, 2015 | 17:07PM EST
  7. Intercept's NASH Trial Design Irks Investors

    IBD | May. 19, 2015 | 11:36AM EST
  8. Buckingham's Top Four New Buys of First Quarter Go Up in Price

    GuruFocus | May. 15, 2015 | 19:25PM EST
  9. Health Care Sector Delivers Healthy Q1 Results

    IBD | May. 15, 2015 | 18:13PM EST
  10. Stocks Mixed; Vipshop Up As It Denies Short-Seller Charges

    IBD | May. 15, 2015 | 17:10PM EST
  11. Leon Cooperman's Omega Advisors Sells Apple, Gilead; Buys Humana, GM And IBM

    Benzinga | May. 15, 2015 | 12:11PM EST
  12. Stocks Give Up Gains: Paycom Dives On Secondary Offering

    IBD | May. 15, 2015 | 11:58AM EST
  13. Drug 'super spending' soars

    IBD | May. 13, 2015 | 18:55PM EST
  14. The Best And Worst ETFs Of The Week Amid Biotech Rebound

    Benzinga | May. 9, 2015 | 10:49AM EST
  15. iShares Rolls Out New Smart Beta ETFs

    Benzinga | May. 8, 2015 | 15:46PM EST
  16. Glaxo Q1 Earnings Miss, But 5-Year Guidance Strong

    IBD | May. 6, 2015 | 12:49PM EST
  17. Mylan Launches Gilead Sciences' Sovaldi Tablets in India

    Benzinga | May. 4, 2015 | 05:31AM EST
  18. Gilead Sciences Remains a Popular Biotech Stock Following Earnings

    GuruFocus | May. 4, 2015 | 00:15AM EST
  19. Making Money With Charles Payne: 05/1/15

    FoxBusiness | May. 1, 2015 | 18:00PM EST
  20. Stocks Rebound Higher; Skyworks Finds Support At 50-Day Line

    IBD | May. 1, 2015 | 13:34PM EST
  21. Stocks Hold Gains, But Investors Underwhelmed With Tesla

    IBD | May. 1, 2015 | 11:52AM EST
  22. Gilead Sciences Rallying Off Q1 Beat: A Technical Look

    Benzinga | May. 1, 2015 | 10:41AM EST
  23. Keep an Eye on These 10 Stocks for May 1, 2015

    Benzinga | May. 1, 2015 | 05:01AM EST
  24. LinkedIn Checks Out, Solars Eclipsed, Tesla Powers Up

    IBD | Apr. 30, 2015 | 19:41PM EST
  25. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 18:50PM EST
  26. Gilead EPS Soars Past Views

    IBD | Apr. 30, 2015 | 18:42PM EST
  27. Making Money With Charles Payne: 04/30/15

    FoxBusiness | Apr. 30, 2015 | 18:00PM EST
  28. Gilead Sciences Beats Q1 Views, Shares Rise

    Benzinga | Apr. 30, 2015 | 17:13PM EST
  29. Top-Rated Biotech Unravels Base-Building Effort

    IBD | Apr. 30, 2015 | 16:27PM EST
  30. Apple Supplier Among 3 Top Earnings Reports Tonight

    IBD | Apr. 29, 2015 | 15:09PM EST
  31. Looking Ahead of Wall Street: Apple, GoPro, Gilead Sciences

    GuruFocus | Apr. 27, 2015 | 17:40PM EST
  32. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  33. AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

    GuruFocus | Apr. 24, 2015 | 14:05PM EST
  34. Biogen Earnings Preview: What To Look For

    IBD | Apr. 23, 2015 | 19:45PM EST
  35. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  36. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  37. Forget Google: 5 Top Stocks With Earnings Thursday

    IBD | Apr. 22, 2015 | 19:31PM EST
  38. Benzinga's M&A Chatter for Tuesday April 21, 2015

    Benzinga | Apr. 21, 2015 | 19:37PM EST
  39. Gilead Sciences

    IBD | Apr. 21, 2015 | 18:48PM EST
  40. Weekly CFO Sells Highlight: Gilead Sciences Inc, CarMax Inc, Anthem Inc.

    GuruFocus | Apr. 20, 2015 | 11:41AM EST
  41. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD | Apr. 17, 2015 | 20:04PM EST
  42. Drug Costs Soar 13% In 2014

    IBD | Apr. 14, 2015 | 19:00PM EST
  43. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 17:48PM EST
  44. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 11:12AM EST
  45. AbbVie Upgraded On $7.8 Billion Imbruvica Potential

    IBD | Apr. 13, 2015 | 11:19AM EST
  46. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD | Mar. 3, 2015 | 17:22PM EST
  47. Making Money With Charles Payne: 02/27/15

    FoxBusiness | Feb. 27, 2015 | 18:00PM EST
  48. ImmunoVaccine Up 24% On Deal With Gilead Sciences

    Benzinga | Feb. 27, 2015 | 12:50PM EST
  49. UPDATE: Gilead Press Release Regarding Phase 3 Harvoni Study

    Benzinga | Feb. 26, 2015 | 15:15PM EST
  50. UPDATE: Gilead Reports Preclinical Data

    Benzinga | Feb. 25, 2015 | 15:29PM EST
Trading Center